Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

The effects of renal denervation on blood pressure, cardiac hypertrophy, and sympathetic activity during the established phase of hypertension in spontaneously hypertensive rats

Abstract

This study aimed to investigate whether renal denervation (RDN) reduces blood pressure and attenuates cardiac hypertrophy with decreasing sympathetic activity in spontaneously hypertensive rats (SHRs), a model of essential hypertension, during the established phase of hypertension. We performed RDN or sham operation in 15-weeks-old SHRs. Thirty days after RDN, mean blood pressure measured by telemetry, heart weight, left ventricular wall thickness assessed by echocardiography, and urinary norepinephrine levels were significantly decreased in the RDN group compared to the Sham group. Furthermore, oxidative stress, as indicated by thiobarbituric acid reactive substances, in the rostral ventrolateral medulla, a pivotal region regulating basal sympathetic tone, was significantly decreased in the RDN group. In conclusion, RDN reduces blood pressure and attenuates cardiac hypertrophy with sympathoinhibition in the established phase of hypertension in SHRs. These findings highlight the sympathoinhibitory effect of RDN and suggest that RDN may be a potential therapy for hypertensive cardiac hypertrophy.

Renal denervation reduces blood pressure and attenuates cardiac hypertrophy with sympathoinhibition in the established phase of hypertension in spontaneously hypertensive rats. This study highlights the sympathoinhibitory effect of renal denervation and suggests that renal denervation may be a potential therapy for hypertensive cardiac hypertrophy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2

References

  1. Hirooka Y. Sympathetic activation in hypertension: importance of the central nervous system. Am J Hypertens. 2020;33:914–26.

    Article  CAS  PubMed  Google Scholar 

  2. Katsurada K, Shinohara K, Aoki J, Nanto S, Kario K. Renal denervation: basic and clinical evidence. Hypertens Res. 2022;45:198–209.

    Article  PubMed  Google Scholar 

  3. Ogoyama Y, Tada K, Abe M, Nanto S, Shibata H, Mukoyama M, et al. Effects of renal denervation on blood pressures in patients with hypertension: a systematic review and meta-analysis of randomized sham-controlled trials. Hypertens Res. 2021. https://doi.org/10.1038/s41440-021-00761-8.

  4. Kiuchi MG, Carnagarin R, Schultz C, Shetty S, Ward NC, Santos CE, et al. Update on advanced interventional neuromodulatory approaches to lower blood pressure. Heart. 2023. https://doi.org/10.1136/heartjnl-2022-321499.

  5. Shinohara K, Kishi T, Hirooka Y, Sunagawa K. Circulating angiotensin II deteriorates left ventricular function with sympathoexcitation via brain angiotensin II receptor. Physiol Rep. 2015;3:e12514.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Tsoporis J, Leenen FH. Effects of arterial vasodilators on cardiac hypertrophy and sympathetic activity in rats. Hypertension. 1988;11:376–86.

    Article  CAS  PubMed  Google Scholar 

  7. Shinohara K, Hirooka Y, Ogawa K, Kishi T, Yasukawa K, Utsumi H, et al. Combination therapy of olmesartan and azelnidipine inhibits sympathetic activity associated with reducing oxidative stress in the brain of hypertensive rats. Clin Exp Hypertens. 2012;34:456–62.

    Article  CAS  PubMed  Google Scholar 

  8. Schlaich MP, Kaye DM, Lambert E, Sommerville M, Socratous F, Esler MD. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation. 2003;108:560–5.

    Article  PubMed  Google Scholar 

  9. Shibata R, Shinohara K, Ikeda S, Iyonaga T, Matsuura T, Kashihara S, et al. Transient receptor potential vanilloid 1-expressing cardiac afferent nerves may contribute to cardiac hypertrophy in accompany with an increased expression of brain-derived neurotrophic factor within nucleus tractus solitarius in a pressure overload model. Clin Exp Hypertens. 2022;44:249–57.

    Article  CAS  PubMed  Google Scholar 

  10. Goldberger JJ, Arora R, Buckley U, Shivkumar K. Autonomic nervous system dysfunction: JACC focus seminar. J Am Coll Cardiol. 2019;73:1189–206.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Triposkiadis F, Briasoulis A, Kitai T, Magouliotis D, Athanasiou T, Skoularigis J, et al. The sympathetic nervous system in heart failure revisited. Heart Fail Rev. 2023. https://doi.org/10.1007/s10741-023-10345-y.

  12. Ikeda S, Shinohara K, Kashihara S, Matsumoto S, Yoshida D, Nakashima R, et al. Contribution of afferent renal nerve signals to acute and chronic blood pressure regulation in stroke-prone spontaneously hypertensive rats. Hypertens Res. 2023;46:268–79.

    Article  CAS  PubMed  Google Scholar 

  13. Wu L-L, Zhang Y, Li X-Z, Du X-L, Gao Y, Wang J-X, et al. Impact of selective renal afferent denervation on oxidative stress and vascular remodeling in spontaneously hypertensive rats. Antioxidants. 2022;11:1003.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Landgraf SS, Wengert M, Silva JS, Zapata-Sudo G, Sudo RT, Takiya CM, et al. Changes in angiotensin receptors expression play a pivotal role in the renal damage observed in spontaneously hypertensive rats. Am J Physiol Ren Physiol. 2011;300:F499–510.

    Article  CAS  Google Scholar 

  15. Oshima N, Onimaru H, Matsubara H, Uchida T, Watanabe A, Takechi H, et al. Uric acid, indoxyl sulfate, and methylguanidine activate bulbospinal neurons in the RVLM via their specific transporters and by producing oxidative stress. Neuroscience. 2015;304:133–45.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by JSPS KAKENHI (JP21K08032, KS; JP20K08431, YH).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Keisuke Shinohara.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Katsuki, M., Shinohara, K., Kinugawa, S. et al. The effects of renal denervation on blood pressure, cardiac hypertrophy, and sympathetic activity during the established phase of hypertension in spontaneously hypertensive rats. Hypertens Res 47, 1073–1077 (2024). https://doi.org/10.1038/s41440-024-01596-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41440-024-01596-9

Keywords

This article is cited by

Search

Quick links